Divi's Laboratories Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Divi's Laboratories Ltd. authored by Deven Choksey and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 4
Author: Deven Choksey

Keep track of all breaking news and updates on Divi's Laboratories Ltd. from all sources in a single place.

Divi's Laboratories Ltd.

05 Sep 2025

Company Update

Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation of cessation of senior management personnel.

pdf

Divi's Laboratories Ltd.

30 Aug 2025

Company Update

Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Clippings - Notice to the shareholders for updating KYC details.

pdf

Divi's Laboratories Ltd.

29 Aug 2025

Steady performance amid near-term headwinds; structural levers intact

Accumulate: Divi's Laboratories Ltd.

Deven Choksey

We have revised our FY26E/FY27E EPS estimates by -14.9%/-22.7%, respectively, as we factor in subdued growth traction in Generic API segment, lower other income and higher depreciation expenses on account of higher investments in its facilities.

Divi's Laboratories Ltd. is trading above its 30 day SMA of 6082.2

Divi's Laboratories Ltd.

12 Aug 2025

Earnings Call

Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Q1FY26 Earnings Conference Call held on 06.08.2025

pdf

Divi's Laboratories Ltd.

11 Aug 2025

AGM

Divis Laboratories Ltd - 532488 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Submission of proceedings of the 35th AGM, Voting results and scrutinizers report.

pdf

Divi's Laboratories Ltd.

11 Aug 2025

AGM

Divis Laboratories Ltd - 532488 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Submission of proceedings of the 35th Annual General Meeting of the Company along with voting results and Scrutinizers report.

pdf

Divi's Laboratories Ltd.

07 Aug 2025

Company Update

Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Clippings regarding unaudited financial results for the quarter ended June 30, 2025

pdf

Divi's Laboratories Ltd.

07 Aug 2025

Divi's Laboratories (DIVI IN) Q1FY26 Result Update Margin...

Accumulate: Divi's Laboratories Ltd.

Target

Prabhudas Lilladhar

Divi's Laboratories (DIVI) Q1FY26 EBITDA was 4% below our estimates led by lower margins despite higher CS revenues. We expect margins to improve, led by better product mix and stable raw material prices. Mgmt. suggested that moderation of raw material prices, increasing RFP's and commencement of some CDMO and contrast media contracts, will continue to aid revenues and margins. Our FY26E/FY27E EPS estimates stand marginally reduced by 3-4%. We expect 20% EBITDA CAGR and 12% PAT CAGR over FY25-27E. At CMP,...